MDEA: Difference between revisions

Line 7:

| ''[[MDEA/Summary|Summary sheet: MDEA]]''

|}

'''MDEA''' (also known as '''3,4-methylenedioxy-N-ethylamphetamine''', '''MDE''' or '''Eve''') is a [[stimulant]] and [[Psychoactive class::entactogen]]ic drug of the [[phenethylamine]] and [[Chemical class::Substituted amphetamines|substituted amphetamine]] classes and a closely related structural analog of [[MDMA]] and [[MDA]]. It is rarely sold on its own and has historically been used as an occasional additive or substitute ingredient in pills of "Ecstasy". In the United States, MDEA was introduced recreationally in 1985 as a legal substitute to the newly banned MDMA before it was made a Schedule 1 substance in the United States on August 13, 1987 under the Federal Analog Act.

'''MDEA''' (also known as '''3,4-methylenedioxy-N-ethylamphetamine''', '''MDE''' or '''Eve''') is a [[stimulant]] and [[Psychoactive class::entactogen]]ic drug of the [[phenethylamine]] and [[Chemical class::Substituted amphetamines|substituted amphetamine]] classes and a closely related structural analog of [[MDMA]] and [[MDA]].

In a 1967 lab notebook entry, Alexander Shulgin briefly mentioned a colleague's report of no effect from the substance with a 100mg dose.<ref>Rediscovering MDMA (ecstasy): the role of the American chemist Alexander T. Shulgin|doi=10.1111/j.1360-0443.2010.02948.x}}</ref> Shulgin later tested the compound at a range of higher doses and characterized the substance in his book [[PiHKAL]].<ref>PiHKAL|http://isomerdesign.com/PiHKAL/read.php?domain=pk&id=106</ref>

MDEA is rarely sold on its own and has historically been used as an occasional additive or substitute ingredient in pills of "Ecstasy". In the United States, MDEA was introduced recreationally in 1985 as a legal substitute to the newly banned MDMA before it was made a Schedule 1 substance in the United States on August 13, 1987 under the Federal Analog Act.

While MDEA shares many of the same entactogenic properties of MDMA, it is slightly less potent and considered to be more "stoning", lacking the pro-socializing and energizing "magic" most party-goers seek in their MDMA/Ecstasy experiences. As a result, it is largely considered by most people to be a less desirable version of MDMA and is thus rarely produced and sold in the illicit drug trade.

@@ Line 7: / Line 7: @@
 | ''[[MDEA/Summary|Summary sheet: MDEA]]''
 |}
-'''MDEA''' (also known as '''3,4-methylenedioxy-N-ethylamphetamine''', '''MDE''' or '''Eve''') is a [[stimulant]] and [[Psychoactive class::entactogen]]ic drug of the [[phenethylamine]] and [[Chemical class::Substituted amphetamines|substituted amphetamine]] classes and a closely related structural analog of [[MDMA]] and [[MDA]]. It is rarely sold on its own and has historically been used as an occasional additive or substitute ingredient in pills of "Ecstasy". In the United States, MDEA was introduced recreationally in 1985 as a legal substitute to the newly banned MDMA before it was made a Schedule 1 substance in the United States on August 13, 1987 under the Federal Analog Act.
+'''MDEA''' (also known as '''3,4-methylenedioxy-N-ethylamphetamine''', '''MDE''' or '''Eve''') is a [[stimulant]] and [[Psychoactive class::entactogen]]ic drug of the [[phenethylamine]] and [[Chemical class::Substituted amphetamines|substituted amphetamine]] classes and a closely related structural analog of [[MDMA]] and [[MDA]].
 In a 1967 lab notebook entry, Alexander Shulgin briefly mentioned a colleague's report of no effect from the substance with a 100mg dose.<ref>Rediscovering MDMA (ecstasy): the role of the American chemist Alexander T. Shulgin|doi=10.1111/j.1360-0443.2010.02948.x}}</ref> Shulgin later tested the compound at a range of higher doses and characterized the substance in his book [[PiHKAL]].<ref>PiHKAL|http://isomerdesign.com/PiHKAL/read.php?domain=pk&id=106</ref>
+MDEA is rarely sold on its own and has historically been used as an occasional additive or substitute ingredient in pills of "Ecstasy". In the United States, MDEA was introduced recreationally in 1985 as a legal substitute to the newly banned MDMA before it was made a Schedule 1 substance in the United States on August 13, 1987 under the Federal Analog Act.
 While MDEA shares many of the same entactogenic properties of MDMA, it is slightly less potent and considered to be more "stoning", lacking the pro-socializing and energizing "magic" most party-goers seek in their MDMA/Ecstasy experiences. As a result, it is largely considered by most people to be a less desirable version of MDMA and is thus rarely produced and sold in the illicit drug trade.